Thomas Kudsk Larsen
Investor Relations Contact chez SANOFI
Profil
Thomas Kudsk Larsen is currently the Head-Investor Relations at Sanofi.
Previously, he worked as an Investor Relations Contact at AstraZeneca PLC.
From 2011 to 2014, he served as the Head-Investor Relations North America at Roche Holdings, Inc. In the future, from 2021 to 2023, he will be the Head-Communication & Investor Relations at Swedish Orphan Biovitrum AB.
Mr. Larsen completed his undergraduate degree at Copenhagen Business School.
Postes actifs de Thomas Kudsk Larsen
Sociétés | Poste | Début |
---|---|---|
SANOFI | Investor Relations Contact | - |
Anciens postes connus de Thomas Kudsk Larsen
Sociétés | Poste | Fin |
---|---|---|
SWEDISH ORPHAN BIOVITRUM AB | Investor Relations Contact | 01/04/2023 |
ASTRAZENECA PLC | Investor Relations Contact | 01/08/2021 |
Roche Holdings, Inc.
Roche Holdings, Inc. Pharmaceuticals: MajorHealth Technology Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Investor Relations Contact | 01/09/2014 |
Formation de Thomas Kudsk Larsen
Copenhagen Business School | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
ASTRAZENECA PLC | Health Technology |
SANOFI | Health Technology |
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
Entreprise privées | 1 |
---|---|
Roche Holdings, Inc.
Roche Holdings, Inc. Pharmaceuticals: MajorHealth Technology Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Health Technology |